Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention

NCT07650968 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

378

Enrollment

OTHER

Sponsor class

Conditions

Acute Urinary Retention
Benign Prostatic Hyperplasia

Interventions

DRUG: Tamsulosin 0.4 mg
DRUG: Tamsulosin 0.8 mg
DRUG: Silodosin 8 mg

Sponsor

Beni-Suef University